Ragifilimab

CAT: 0804-HY-P99812-01Size: 1 mgDry Ice: YesHazardous: No
CAT#:0804-HY-P99812-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody targeting the glucocorticoid-induced TNFR-related protein (GITR) . Ragifilimab binds to and activates GITR on T cells, which stimulates the immune system to enhance its anti-tumor activity. Ragifilimab can be used for advanced or metastatic solid tumors research[1].
CAS Number
[2207590-51-8]
Product Name Alternative
INCAGN-1876
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ragifilimab.html
Purity
99.32
Solubility
H2O
Smiles
[Ragifilimab]
Molecular Weight
(146.46 kDa)
References & Citations
[1]Hernandez-Guerrero T, et al: Not Ready for Prime Time. Clin Cancer Res. 2022 Sep 15;28 (18) :3905-3907.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
TNFRSF18/GITR/CD357

Alternative Products

CatalogName
abx831678-01Ragifilimab
E55B0480Ragifilimab (Reference antibody)
DHJ89801Research Grade Ragifilimab
KDJ89801Ragifilimab ELISA Kit
21-956Ragifilimab - Research Grade Biosimilar
ICH5800-1mgRagifilimab Biosimilar - Research Grade
A138720Ragifilimab Biosimilar (Monoclonal, IgG4)
MBS189287-01Anti-GITR/TNFRSF18(ragifilimab) mAb
A137552Ragifilimab Biosimilar (Monoclonal, IgG4, kappa)
C00144-01Ragifilimab (Anti-TNFRSF18 / GITR / CD357)

Popular Products